Agnes Martin

Agnes Martin has extensive experience in the field of cancer research and pharmacology. Agnes started their career at Merck as an Industrial Placement Student in 2002. Agnes then worked at Quotient Bioresearch Ltd as a Scientist from 2008 to 2009 before joining Astex Pharmaceuticals as a Research Associate from 2010 to 2013. Agnes then moved to Cancer Research UK (CRUK), working as a Principal Scientist from 2013 to 2018, Group Leader from 2018 to 2022, and currently holds the role of Associate Director at CRUK focusing on Mechanistic Pharmacology. Agnes'swork history demonstrates a progression in roles and responsibilities within the pharmaceutical and cancer research industry.

Agnes Martin pursued a Bachelor of Science in Biotechnology with a year in industry at Imperial College London from 2000 to 2004. Agnes then completed a Doctor of Philosophy in Pharmacology at the University of Cambridge from 2004 to 2008.